Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HDAC-IN-52 is a pyridine-containing HDAC inhibitor that inhibits HDAC1, HDAC2, HDAC3 and HDAC10 with IC50s of 0.189, 0.227, 0.440 and 0.446 μM, respectively. HDAC-IN-52 can be used in cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 440.00 | |
10 mg | In stock | $ 648.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,390.00 | |
100 mg | In stock | $ 1,870.00 | |
500 mg | In stock | $ 3,730.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 486.00 |
Description | HDAC-IN-52 is a pyridine-containing HDAC inhibitor that inhibits HDAC1, HDAC2, HDAC3 and HDAC10 with IC50s of 0.189, 0.227, 0.440 and 0.446 μM, respectively. HDAC-IN-52 can be used in cancer research. |
Targets&IC50 | HDAC10:0.446 μM, HDAC1:0.189 μM, HDAC3:0.440 μM, HDAC2:0.227 μM |
In vitro |
HDAC-IN-52 (72 h) inhibited the proliferation of HCT116, A549 and K562 cells with IC50 values of 0.43, 1.28 and 0.37 μM, respectively.[1 ]. HDAC-IN-52 (1-5 μM ; 24-48 h) significantly induced cell death in leukemic U937 cells after 48 h, with 76% and 100% G1 prophase blockade, respectively.[1 ] HDAC-IN-52 (1-5 μM ; 48 h) increased mRNA expression of p21, BAX and BAK and downregulated cyclin D1 and BCL-2.[1 ] |
Molecular Weight | 396.44 |
Formula | C24H20N4O2 |
CAS No. | 2075787-77-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (63.06 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HDAC-IN-52 2075787-77-6 Chromatin/Epigenetic DNA Damage/DNA Repair HDAC inhibitor inhibit